drugset / Trial / NCT03605758

Treatment of Strongyloides Infection

NCT03605758

Phase 3 Terminated 51 enrolled Albert Einstein College of Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the serologic response in patients with S. stercoralis infection after treatment with a regimen of two single doses of 200 µg/kg of ivermectin given 2 weeks apart versus a regimen of two single doses of 200 µg/kg of ivermectin given in two consecutive days.

Timeline

Start
2012-05
Primary completion
2015-02-05
Completion
2015-02-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivermectin Small molecule 200 ug/kg

Indications